A detailed history of Pekin Hardy Strauss, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 4,165 shares of NVO stock, worth $430,827. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,165
Previous 7,165 41.87%
Holding current value
$430,827
Previous $1.02 Million 51.57%
% of portfolio
0.07%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $357,210 - $436,259
-3,000 Reduced 41.87%
4,165 $495,000
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $147,252 - $176,292
1,200 Added 20.12%
7,165 $1.02 Million
Q1 2024

May 02, 2024

BUY
$102.11 - $135.92 $347,684 - $462,807
3,405 Added 133.01%
5,965 $765,000
Q4 2023

Feb 05, 2024

BUY
$87.78 - $105.45 $224,716 - $269,952
2,560 New
2,560 $264,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pekin Hardy Strauss, Inc. Portfolio

Follow Pekin Hardy Strauss, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.